Abeona Therapeutics Inc (ABEO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abeona Therapeutics Inc   (NASDAQ: ABEO)


Abeona Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Abeona Therapeutics Inc's ROI in the second quarter of 2026?
Abeona Therapeutics Inc recorded a cumulative net loss of $-63 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -36.05%.

Within the Healthcare sector 410 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 137 to 145.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 43.1 % 92.03 % 79.91 % 78.57 % 69.1 %
Y / Y Net Income Change TTM - - - - 672.91 %
Investment (TTM) in Millions 155 162 172 209 212
Return On Investment (TTM) -36.05 % 35.05 % 42.25 % 55.42 % 46.96 %
ABEO's Overall Ranking # 145 # 137 # 81 # 93 # 3860
Seq. Investment Change TTM -7.55 % 11.99 % 13.4 % 21.89 % 24.06 %
Seq. Net Income Change TTM - -7.09 % -13.56 % 43.86 % -
Net Income (TTM) in Millions -63 66 71 82 57

ABEO Company Profile >> Back to ABEO Roi Comparisons >> See Annual ABEO Return On Investment



Return On Investment ABEO's Ranking
Within: No.
Industry # 163
Sector # 411
Overall # 145

Return On Investment Statistics
High Average Low
55.42 %
-93.13 %
-1821.07 %
(Sep 30 2025)   (Mar 31 2015)







Financial Statements
Abeona Therapeutics Inc's II. Quarter Investments $ 155 Millions ABEO's Balance sheet
Abeona Therapeutics Inc's II. Quarter Income $ -20 Millions Quarterly ABEO's Income Statement
ABEO's Income by Division See ABEO's Income by Division


ABEO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 172 92 51 56 63
Y / Y Investment Growth 86.22 % 82.57 % -10.37 % -10.37 % -42.36 %
Net Income in Millions 71 -64 -54 -40 -85
Y / Y Net Income Growth - - - - -
Annual Return On Investment 41.39 % -69.02 % -107.13 % -70.34 % -134.9 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 41.39 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ABEO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ABEO's Competitors
Subscribers only: Roi for Abeona Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ABEO's Customers

Other Ratios
ABEO's Roa ABEO's Inventory Turnover Ratio ABEO's Growth Rates ABEO's Dividend Statistics
ABEO's Profitability Ratios ABEO's Asset Turnover Ratio ABEO's Dividend Growth
ABEO's Roe ABEO's Valuation Ratios ABEO's Financial Strength Ratios ABEO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-03T11:26:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.